Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Azria, David" or (type any "bookEditor journalEditor issueEditor" and editor="Azria, David")

Add to list
- Journal Article
- A1
- open access
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Juan C. Rosas, Miguel E. Aguado‐Barrera, David Azria, Erik Briers, Rebecca Elliott, Marie‐Pierre Farcy‐Jacquet, Alexandra Giraldo, Sara Gutiérrez‐Enríquez, Tiziana Rancati, Tim Rattay, et al.

(2023) INTERNATIONAL JOURNAL OF CANCER. 153(9). p.1579-1591
Add to list
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Philipp Heumann, Miguel E. Aguado-Barrera, Barbara Avuzzi, David Azria, Erik Briers, Renée Bultijnck (UGent) , Ananya Choudhury, Dirk De Ruysscher, Marie-Pierre Farcy-Jacquet, Valerie Fonteyne (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 178.
Add to list
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes

Vincent Vakaet (UGent) , Pieter Deseyne (UGent) , Renée Bultijnck (UGent) , Giselle Post (UGent) , Catharine West, David Azria, Celine Bourgier, Marie-Pierre Farcy-Jacquet, Barry Rosenstein, Sheryl Green, et al.

(2023) ACTA ONCOLOGICA. p.1-9
Add to list
- Journal Article
- A1
- open access
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Harkeran K. Jandu, Colin D. Veal, Laura Fachal, Craig Luccarini, Miguel E. Aguado-Barrera, Manuel Altabas, David Azria, Adinda Baten, Celine Bourgier, Renée Bultijnck (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 187.
Add to list
- Journal Article
- A1
- open access
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort

Adam J. Webb, Emily Harper, Tim Rattay, Miguel E. Aguado-Barrera, David Azria, Celine Bourgier, Muriel Brengues, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, et al.

(2022) EBIOMEDICINE. 84.
Add to list
- Journal Article
- A1
- open access
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Claudio Fiorino, Cesare Cozzarini, Liv Veldeman (UGent) , Renée Bultijnck (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) FRONTIERS IN ONCOLOGY. 12.
Add to list
- Journal Article
- A2
- open access
Development and optimization of a machine-learning prediction model for acute desquamation after breast radiation therapy in the multicenter REQUITE cohort

Mahmoud Aldraimli, Sarah Osman, Diana Grishchuck, Samuel Ingram, Robert Lyon, Anil Mistry, Jorge Oliveira, Robert Samuel, Leila E.A. Shelley, Daniele Soria, et al.

(2022) ADVANCES IN RADIATION ONCOLOGY. 7(3).
Add to list
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Lotte van der Weijst (UGent) , David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 176. p.127-137
Add to list
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der Weijst (UGent) , Miguel E. Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, et al.

(2022) LUNG CANCER. 166. p.228-241
Add to list
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William Hall, Kim De Ruyck (UGent) , et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 168. p.75-82

Academic Bibliography

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Development and optimization of a machine-learning prediction model for acute desquamation after breast radiation therapy in the multicenter REQUITE cohort

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Contents

Support

Contact